Home Sensulin

Sensulin

In operation
Series B
Diabetes Drug Developer

Basic Information

Sensulin, LLC is developing a true once-a-day glucose-responsive insulin that mimics the function of a healthy human pancreas. Sensulin can eliminate the need for basal and pre-meal insulin, significantly improve the level of care, and, most importantly, offer people with diabetes the chance to live a normal life.
Sensulin, LLC
OklahomaCity,Oklahoma,United States of America
less than 15 people
August 09, 2011
info@sensulin.com